Department of Radiotherapy

News and Publication

Dept. data last updated on :28/09/2026

NEWS AND PUBLICATION OF THE DEPARTMENT

  1. Khan, Mohsin; Arshida, P.; Akram, Mohammad; Alam, Shadab; Gupta, Tanisha. Beyond cancer antigen-125: The emerging role of red cell distribution width as a marker of response in ovarian cancer patients receiving neoadjuvant chemotherapy. Annals of Oncology Research and Therapy 6(1):p 20-25, Jan–Jun 2026. | DOI: 10.4103/aort.aort_16_2

  2. Gupta, T., Khan, M., Akram, M., & Hussain, M. A. B. (2026). Dual role of metformin as a chemosensitizer and normal tissue protectant: Does it improve the therapeutic ratio? – A narrative reviewAnnals of Oncology Research and Therapy https://doi.org/10.4103/aort.aort_10_26

  3. Sofi, M. H., Khan, M., Saiyeda, K., Akhtar, J., Gupta, T., & Arshida, P. (2025). Peripheral Neutrophil-to-lymphocyte Ratio: A Predictive Marker of Response in Patients of Head-and-neck Cancer Who Underwent Definitive Chemoradiotherapy?. Journal of Radiation and Cancer Research, 17(1), 18–23.
    https://doi.org/10.4103/jrcr.jrcr_10_25.

  4. Shruti Bansal, Shahid Ali Siddiqui, Zehra Mohsin, Mohsin Khan. Treatment Outcomes of Cobalt-60 Source Based High-Dose-Rate Intra-Cavitary Brachytherapy for Cervical Cancer. International Journal of Science and Research (IJSR), Volume 14 Issue 8, August 2025.

  5. Khazir M, Akram M, Afrose R, Alam MS, Khan M. Cancers in adolescents and young adults (AYA) population: 5 year experience from a cancer registry in India. J Can Res Ther 2025;21:1046-51

  6. Menon P, Badar A, Zaheer S, Akram M, Philip KP, Alam K, Arif Z. Beyond the tumor: The silent influence of lung carcinoma milieu on the architectural and obligational facets of human serum albumin. Journal of Molecular Liquids. 2025 Jul 1:128042.

  7. Arshida, P.; Khan, Mohsin; Hussain, Bilal; Alam, Mehtab1; Zaheer, Samreen; Alam, Shadab; Akram, Mohammad. Can Curcumin Achieve Radiosensitization Beyond that Achieved with Concurrent Chemotherapy in Head and Neck Cancers?. Amrita Journal of Medicine 21(4):p 221-231, October-December 2025. | DOI: 10.4103/AMJM.AMJM_34_25.

  8. Aden, D., Zaheer, S., Sureka, N., Trisal, M., Chaurasia, J. K., & Zaheer, S. (2025). Exploring immune checkpoint inhibitors: Focus on PD-1/PD-L1 axis and beyond. Pathology, research and practice, 269, 155864. https://doi.org/10.1016/j.prp.2025.155864.

  9. Arshida, P.; Khan, Mohsin; Hussain, Bilal; Alam, Mehtab1; Zaheer, Samreen; Alam, Shadab; Akram, Mohammad. Assessing the Protective Role of Nanocurcumin in Mitigating Acute Toxicities among Head-and-Neck Cancer Patients Receiving Concurrent Chemoradiation. Journal of Radiation and Cancer Research 16(4):p 162-168, Oct–Dec 2025. | DOI: 10.4103/jrcr.jrcr_11_25

  10. Agrawal, A., Zaheer, S. & Akram, M. Chemoradiotherapy Plus High-dose-rate Intraluminal Brachytherapy Versus Chemoradiotherapy Alone in Locally Advanced Esophageal Carcinoma: A Single Center Experience with Limited Infrastructure. Indian J Surg Oncol (2025). https://doi.org/10.1007/s13193-025-02192-0

  11. G K, Khan AA, Zaheer S, Ahuja S, Zaheer S. Evaluating Biomarker Dynamics in Breast Cancer Post-Neoadjuvant Chemotherapy: A Retrospective Cross-sectional Study: Biomarker Dynamics in Breast Cancer Post-NAC. Arch Breast Cancer [Internet]. 2024 Oct. 25 [cited 2025 Apr. 19];11(4). Available from: https://www.archbreastcancer.com/index.php/abc/article/view/986

  12. Malik S, Sureka N, Ahuja S, Aden D, Zaheer S, Zaheer S. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire. Cell Biol Int. 2024 Oct;48(10):1406-1449. doi: 10.1002/cbin.12226. Epub 2024 Jul 25. PMID: 39054741.

  13. Aden D, Sureka N, Zaheer S, Chaurasia JK, Zaheer S. Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment. Immunology. 2025 Jan;174(1):30-72. doi: 10.1111/imm.13871. Epub 2024 Oct 27. PMID: 39462179.

  14. Ahmad F, Akram M, Khan M. Concurrent chemoradiation with low-dose and long-duration weekly infusion of gemcitabine in unresectable squamous cell carcinoma of head and neck (SCCHN). J Cancer Res Ther. 2024 Apr 1;20(3):827-831. doi: 10.4103/jcrt.jcrt_2271_22. Epub 2024 Jun 27. PMID: 39023590.

  15. Mohsin Khan , Zarmina Alam , Shahid Ali Siddiqui , Mohd Akram , Mohd Shadab Alam. Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies. Asian Journal of Oncology. eFirst. DOI https://doi.org/ 10.1055/s-0042-1750086

  16. Zarmina Alam, Mohsin Khan, Shahid Ali Siddiqui, Mohd Akram, Mohd Shadab Alam, M. A. Bilal Hussain. Hyperfractionated concurrent chemoradiation against conventional concurrent chemoradiation in locally advanced head and neck carcinoma: a prospective randomised trial. J Xiangya Med 2022;7:2

  17. Mohsin Khan, M. A. Bilal Hussain, Shahid Ali Siddiqui, Mohd Akram. Five-year survival outcomes with two different high dose rate brachytherapy schedules used in the treatment of cervical carcinoma. Therapeutic Radiology and Oncology  2022;6:2 

Performance of Resident in UPAROICON 2020


The Residents from the department actively attended the 32nd Annual State Conference of Association of Radiation Oncologist of India-UP Chapter (UPAROICON) , 18th & 19th December 2021 at Agra.

Dr. Vibhav (JR-2) won the 1st Prize - Best Poster in the category of non thesis poster presentation

The Team consisting of JRs won the Runner up in OncoQuiz.